All
All
Parallel
Title
Appellant
Respondent
Lawyer
Parallel Search is an AI-driven legal research functionality that uses natural language understanding to find conceptually relevant case law, even without exact keyword matches.
Hi, I'm AMICUS. Your GPT powered virtual legal assistant.
Let's chat.
Log in
Sign Up
Select Country
India
UK
&
Ireland
AMICUS AI
CaseIQ
Keyword Research
Parallel Search
Browse
Commentaries
Columns
My Project
New chat
Federal
U.S. Supreme Court
Federal Circuit
1st Circuit
2d Circuit
3d Circuit
4th Circuit
5th Circuit
6th Circuit
7th Circuit
8th Circuit
9th Circuit
10th Circuit
11th Circuit
Court of Appeals for the D.C. Circuit
Board of Immigration Appeals
Special Courts
Bankruptcy
State
Alabama
Alaska
Arkansas
Arizona
California
Colorado
Connecticut
Delaware
District Of Columbia
Florida
Georgia
Guam
Hawaii
Iowa
Idaho
Illinois
Indiana
Kansas
Kentucky
Louisiana
Massachusetts
Maryland
Maine
Michigan
Minnesota
Missouri
Mississippi
Montana
Nebraska
North Carolina
North Dakota
New Hampshire
New Jersey
Northern Mariana Islands
New Mexico
Nevada
New York
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Virginia
Vermont
Washington
Wisconsin
West Virginia
Wyoming
1 Tex. Admin. Code § 354.1891 : ADMINISTRATION — TEXAS HEALTH AND HUMAN SERVICES COMMISSION — MEDICAID HEALTH SERVICES — PHARMACY SERVICES — AUDITS — Vendor Drug Providers Subject to Audit
Text
(a)
All providers participating in the Vendor Drug Program (Program) are subject to periodic audits by the Texas Health and Human Services Commission (the Commission) or contractors for the Centers for Medicare & Medicaid Services.
(b)
Audits determine provider compliance with all state and federal program policies, procedures, and limitations as well as compliance with the requirements outlined in the provider's contract. Data for transactions selected for audit are compared with data on the corresponding prescriptions. Erroneous payments and overpayments that occur because of noncompliance with Program requirements are considered exceptions subject to restitution to the Commission.
(c)
If a provider disagrees with the initial findings of an audit, the provider may present additional documentation to the auditor for review within 15 calendar days of the provider's receipt of the draft audit report. No additional documentation is accepted after this time. The auditor considers the additional documentation before issuing the Final Audit Report.
(d)
If the provider disagrees with the Final Audit Report and wants to appeal, and the findings of the audit do not include findings that the pharmacy engaged in Medicaid fraud, the Commission's Appeals Division, upon receipt of written request, provides an informal hearing. The Commission's Appeals Division must receive the written request for an informal hearing within 15 calendar days of the provider's receipt of the Final Audit Report.
(e)
An administrative law judge (ALJ) from the Commission's Appeals Division conducts hearings requested under subsection (d) of this section in an informal manner. Unless specified by the ALJ and at the ALJ's sole discretion, neither the Texas Rules of Civil Procedure nor the Texas Rules of Evidence or any other procedural or evidentiary rules apply. The ALJ only considers data or documentation provided to the auditors on or before the time specified in subsection (c) of this section. The ALJ makes the final decision. Vendor Drug Program staff who have expertise in the law governing pharmacies' participation in Medicaid are available to the ALJ to answer questions.
1 Tex. Admin. Code § 354.1891
The provisions of this §354.1891 adopted to be effective November 16, 1987, 12 TexReg 3553; transferred effective September 1, 1993, as published in the Texas Register September 7, 1993, 18 TexReg 5978; transferred effective September 1, 2001, as published in the Texas Register May 24, 2002, 27 TexReg 4562; Amended to be effective June 19, 2003, 28 TexReg 4543; Amended by Texas Register, Volume 41, Number 08, February 19, 2016, TexReg 1221, eff. 2/25/2016
×